艾伯維藥品 ABBV
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 228.49 | -3,270 | 1,816 | 1.36 | 133,960 | |
| 2025Q3 | 231.54 | -2,642 | 186 | 0.14 | 133,898 | |
| 2025Q2 | 185.62 | -183 | 938 | 0.69 | 137,182 | |
| 2025Q1 | 209.52 | 1,420 | 54.20 | 1,286 | 0.95 | 136,165 |
| 2024Q4 | 177.70 | 3,325 | -0.47 | -22 | -0.02 | 135,161 |
| 2024Q3 | 197.48 | 6,032 | 24.37 | 1,561 | 1.09 | 143,422 |
| 2024Q2 | 171.52 | 6,778 | 18.53 | 1,370 | 0.94 | 141,937 |
| 2024Q1 | 182.10 | 8,007 | 14.91 | 1,369 | 0.97 | 148,874 |
| 2023Q4 | 154.97 | 10,360 | 7.32 | 822 | 0.61 | 134,711 |
| 2023Q3 | 149.06 | 12,094 | 14.25 | 1,778 | 1.31 | 136,221 |
| 2023Q2 | 134.73 | 12,866 | 15.49 | 2,024 | 1.50 | 135,367 |
| 2023Q1 | 159.37 | 13,274 | 1.57 | 239 | 0.17 | 134,544 |
| 2022Q4 | 161.61 | 17,254 | 14.88 | 2,473 | 1.77 | 138,805 |
| 2022Q3 | 134.21 | 15,994 | 25.77 | 3,949 | 2.78 | 141,325 |
| 2022Q2 | 153.16 | 14,653 | 5.97 | 924 | 0.65 | 143,186 |
| 2022Q1 | 162.11 | 16,283 | 28.34 | 4,490 | 3.10 | 143,211 |
| 2021Q4 | 135.40 | 15,408 | 27.93 | 4,044 | 2.74 | 146,529 |
| 2021Q3 | 107.87 | 13,550 | 24.34 | 3,179 | 2.14 | 148,858 |
| 2021Q2 | 112.64 | 12,569 | 5.83 | 766 | 0.51 | 147,972 |
| 2021Q1 | 108.22 | 13,710 | 26.53 | 3,553 | 2.36 | 150,501 |